HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lysosomal sialidase deficiency in sialidosis with partial beta-galactosidase deficiency.

Abstract
We analyzed the subcellular localization of sialidases in human lymphocytes from a patient with adult type sialidosis with partial beta-galactosidase deficiency and normal controls. Sialidase activities were measured with alpha,2 leads to 3 NeuAc-lactitol, 4-methylumbelliferyl-NeuAc and GM3 ganglioside as substrates. Sialidases in the lysosomes were sonication-labile and hydrolyzed mainly hydrophilic substrates such as NeuAc-lactitol and 4-methylumbelliferyl-NeuAc, but hydrolyzed subsidiarily GM3 ganglioside. On the other hand, sialidases in the plasma membrane were sonication-stable and hydrolyzed both hydrophilic substrates and GM3 ganglioside. In sialidosis with partial beta-galactosidase deficiency, the sialidases of the lysosomes showed 3-5% activity toward hydrophilic substrates and 25% activity toward GM3 ganglioside as compared with sialidase activities of the controls. However, there are no differences in the activities of the sialidases in the plasma membrane. These results demonstrate that the essential defect in this disease is the deficiency of a lysosomal sialidase.
AuthorsT Yamada, S Tsuji, T Ariga, T Miyatake
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 755 Issue 1 Pg. 106-11 (Jan 04 1983) ISSN: 0006-3002 [Print] Netherlands
PMID6402033 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Neuraminidase
  • beta-Galactosidase
Topics
  • Carbohydrate Metabolism, Inborn Errors (enzymology)
  • Cell Membrane (enzymology)
  • Humans
  • Lactose Intolerance (complications, enzymology)
  • Lymphocytes (enzymology)
  • Lysosomes (enzymology)
  • Male
  • Middle Aged
  • Neuraminidase (blood, deficiency)
  • Reference Values
  • Subcellular Fractions (enzymology)
  • beta-Galactosidase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: